Could an asthma medication be the next fat-melter? Kybella in the test phase.

Answer: Maybe. Lithera, Inc. – a privately held pharmaceutical research group, recently presented some exciting results of a randomized, double-blinded study of their new injectable lipolysis drug, called “LIPO102″ at the ASDS meeting. In the study, volunteers were injected weekly in 22 locations in the abdomen and flanks with the drug, over 8 weeks. On average, the study […]